Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Heiner Dreismann joins Noscendo’s Board of Directors
, /in E-News /by panglobalNoscendo, a leading diagnostic company for identification and assessment of bloodstream associated pathogens and other infections has appointed Heiner Dreismann, former President and CEO of Roche Molecular Systems, to its Board of Directors.
Mogrify appoints Tom Graney as Non-Executive Director, Audit Chair and Capital Markets Advisor
, /in E-News /by panglobalMogrify, a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, has appointed Tom Graney CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He joins senior biopharma industry executives, Dr. Jane Osbourn OBE (Chair) and Dr. Lorenz Mayr, as […]
Dotmatics partners with RockStep Solutions to provide integrated solution for digitalized in vivo drug discovery
, /in E-News /by panglobalDotmatics, a science company that provides leading-edge scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, announced a partnership with RockStep Solutions, a developer of software tools for managing data and operations for in vivo research. The collaboration combines the simple, unified, realtime access to all research data […]
BioNet and BIA Separations collaborate on production process development of mRNA vaccines
, /in E-News /by panglobalBioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, announced the successful development of an optimized mRNA manufacturing process.
Biofortuna doubles their manufacturing space to meet demand
, /in E-News /by panglobalBiofortuna, a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.
Aragen expects to ride wave of US biotech growth in 2022 on back of demand for CDMO services
, /in E-News /by panglobalHyderabad, India-based Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth in 2022, with NCE development and manufacturing business growing at around 40% year-on-year.
True Mass presents first commercial CDMS instrument to support analysis of macromolecules
, /in E-News /by panglobalTrueMass presented the world’s first commercially designed charge detection mass spectrometer (CDMS) at this year’s American Society of Mass Spectrometry conference in Philadelphia, PA, early November.
With a little help from the patients: Automated measurement of tacrolimus from dried blood spots
, /in Featured Articles /by panglobalTherapeutic drug monitoring (TDM) of tacrolimus is mandatory because this immunosuppressive drug that is frequently prescribed in transplant patients, exhibits a high interpatient pharmacokinetic variability. This study explored the possibility of performing TDM using dried blood spots that can be collected by the patients themselves and that can be analysed by a fully-automated extraction module […]
Digitization of health
, /in Featured Articles /by panglobalThe development of appropriate technical instrumentation for both sample and data analysis in recent years has driven progress in the field of metabolomics. CLI chatted to Dr Ali Tinazli (CEO at lifespin GmbH) to find out more about how this process of ‘digitizing health’ is developing and what it will mean for us as inidviduals.
Multiparameter autoantibody testing in autoimmune neurological diseases
, /in Featured Articles /by panglobalIn recent years, there has been a growing understanding of the pathology of autoimmune neurological disorders, and the identification of the causal autoantibodies has allowed the definition of new diseases. As these diseases have a multifaceted clinical presentation, comprehensive neural autoantibody testing is a central part of diagnosis. This article describe the current knowledge of […]